INTRODUCTION
Hepatocellular carcinoma may develop from multistep carcinogenesis via dysplastic nodules in the cirrhotic liver. The first stage between high-grade dysplastic nodule to overt hepatocellular carcinoma is vaguely nodular, early hepatocellular carcinoma. The consensus on the nomenclature and pathologic characteristics of both entities were recently established by an international consensus group for hepatocellular neoplasia, 1 and were adopted in the recent World Health Organization series of tumor classification. 2 We present herein a case of early hepatocellular carcinoma in a 58-year-old man with B-viral macronodular cirrhosis. We discuss the histopathologic features and differential diagnosis from high-grade dysplastic nodule of the liver.
CASE SUMMARY
A 58-year-old male was transferred to our hospital for surgery to remove a recently found liver mass. The liver nodule was found on abdominal ultrasound during a regular checkup. The hepatocellular carcinoma was suspected after subsequent abdominal computed tomography (CT) at a private clinic.
The initial hematologic and blood chemistry data were as follows: white blood cell count, 6,000/μL; hemoglobin, 14.6 g/dL;
platelet count, 81,000/μL; blood urea nitrogen, 13 mg/dL; creatinine, 0.7 mg/dL; albumin, 3.5 g/dL; aspartate aminotrans- A few portal tracts are noted in the lower portion. (B) The nuclear density is increased to more than twice that of the surrounding nonneoplastic liver (A: H-E, ×100; B: H-E, ×400).
tumor capsule or pseudocapsule. Residual portal tracts could be observed within the nodule (Fig. 3A) . The nuclear density was variably increased, mostly more than twice that of normal hepatocytes. The cell size was constant, but smaller than usual and with an increased nuclear cytoplasmic ratio, consistent with small-cell change (Fig. 3B) . A few foci of stromal invasion were noted within and around the portal tract (Fig. 4A) . These findings were highlighted by immunohistochemistry for cytokeratin 7 (Fig. 4B) . Sinusoidal capillarization was not evident and was rather focally localized in the periphery of the dysplastic portion.
Foci of portal vein invasion was not found. The use of these markers may help to discriminate the equivocal nodule, but may also lead to false confidence, particularly in the case of limited samples, such as those obtained by needle biopsy.
Therefore, a final decision of early hepatocellular carcinoma can only be drawn on the basic findings of routine hematoxylinand-eosin staining, such as abnormal-appearing cytologic and architectural findings, with meticulous effort to find the foci of stromal invasion.
